News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
5966
Sources here
10
Companies here
37
Search results Stored financial headlines

Active search

5966 matching headlines

Ticker or company: GENMain company stories
Clear
Latest

finance.yahoo.com Earnings

argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

argenx SE Study met primary endpoint of mean Total Improvement Score (TIS) at Week 52 in the combined study population of IMNM and DM patients (p=0.0011) Patient improvements observed early and sustained throughout study; consistent treatment effect across IMNM and DM First Phase 3 study to show statistically significant and clinically meaningful improvements in disease activity in IMNM, …

Cathay General Bancorp declares $0.38 dividend

* Cathay General Bancorp (CATY [https://seekingalpha.com/symbol/CATY]) declares $0.38/share quarterly dividend [https://seekingalpha.com/pr/20620152-cathay-general-bancorp-declares-0_38-per-share-dividend], in line with previous. * Payable Sept. 8; for shareholders of record Aug. 28; ex-div Aug. 28. * See CATY Dividend Scorecard, Yield Chart, & Dividend Growth. [https://seekingalpha.com/symbol/CATY/dividends?source=news_bullet] MORE ON CATHAY GENERAL BANCORP …

CATY main company
Sharemaestro market context Trend signal active 52 weeks +33.1% CATY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Q2 Earnings Highs And Lows: Cogent (NASDAQ:CCOI) Vs The Rest Of The Telecommunication Services Stocks

Q2 Earnings Highs And Lows: Cogent (NASDAQ:CCOI) Vs The Rest Of The Telecommunication Services Stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today we are looking at Cogent …

CCOI main company
Sharemaestro market context Price below Trend Line 52 weeks -70.4% CCOI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Mercury General (MCY) Fully Priced On Its Oklahoma Homeowners Product Update?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Mercury General (MCY) is back on investors' radar after Mercury Insurance introduced an enhanced homeowners product in Oklahoma, adding new hail, wind and wildfire related discounts and …

MCY main company
Sharemaestro market context Trend signal active 52 weeks +39.9% · Next-week setup positive 56.4% MCY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Banco Bilbao Vizcaya Argentaria (BME:BBVA) Draws Options Attention, Is The Stock Fully Valued?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Banco Bilbao Vizcaya Argentaria (BME:BBVA) is drawing fresh attention after the September 18, 2026 €25.00 call option showed some of the highest implied …

BBVA main company BILB34 main company BBVA main company BOY main company BBVA main company BBVA main company +1 more
Sharemaestro market context Trend signal active 52 weeks +38.4% · Next-week setup positive 61.9% BBVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Should Income Investors Look At Amgen Inc. (NASDAQ:AMGN) Before Its Ex-Dividend?

Amgen Inc. (NASDAQ:AMGN) is approaching its ex-dividend date, with a trailing yield of 2.4% and an upcoming dividend of US$2.52 per share. The company's dividend payouts are covered by both profit (60% payout ratio) and free cash flow (52% consumed), suggesting sustainability. While earnings …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Private Advisory Group LLC Purchases New Shares in General Mills, Inc. $GIS

Private Advisory Group LLC recently acquired a new stake of 318,192 shares in General Mills, Inc. (NYSE:GIS), valued at approximately $11.07 million. This move is part of a broader trend of institutional investment, with hedge funds and other institutional investors owning 75.71% of the …

GIS main company
Sharemaestro market context Price above Trend Line 52 weeks -18.5% · Next-week setup negative 43.9% GIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amgen Inc. $AMGN Shares Sold by Strive Financial Group LLC

Strive Financial Group LLC significantly reduced its stake in Amgen Inc. by 69.5% in the second quarter, selling 4,466 shares and retaining 1,957 shares valued at approximately $709,000. Despite this, Amgen reported strong quarterly earnings of $6.29 per share on $10.05 billion in revenue, …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

USA Financial Formulas Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN

USA Financial Formulas has acquired a new stake in Regeneron Pharmaceuticals (NASDAQ:REGN), purchasing 1,457 shares valued at approximately $1.13 million, making it their 27th-largest portfolio holding. Institutional investors collectively own 83.31% of Regeneron, with several major firms significantly increasing their positions. The company recently …

REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +36.8% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co.

Meyer Handelman Co. decreased its stake in Amgen Inc. by 4% in the second quarter, selling 4,645 shares but still retaining 111,120 shares valued at $40.2 million. Amgen reported strong quarterly results with earnings of $6.29 per share and revenue of $10.05 billion, a …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Todd Asset Management LLC Sells 19,948 Shares of Amgen Inc. $AMGN

Todd Asset Management LLC has reduced its stake in Amgen Inc. by 15.6%, selling 19,948 shares but still holding 108,134 shares worth approximately $39.2 million. Other institutional investors have also adjusted their positions in Amgen, which recently reported strong quarterly earnings exceeding analyst estimates …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TD Asset Management Inc Boosts Stock Holdings in Amgen Inc. $AMGN

TD Asset Management Inc. increased its stake in Amgen Inc. by 3.9% in the second quarter, now holding 420,259 shares valued at $152.2 million. Other institutional investors like Vanguard Group and State Street Corp also significantly boosted their holdings. Despite a "Hold" consensus rating …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Royal Bank of Canada Sells 86,932 Shares of Genpact Limited $G

Royal Bank of Canada reduced its stake in Genpact Limited (NYSE:G) by 50.1%, selling 86,932 shares but retaining 86,500 shares valued at approximately $3.22 million. Institutional investors now own 96.03% of Genpact, and analysts maintain a "Hold" rating with an average price target of …

G main company
Sharemaestro market context Price below Trend Line 52 weeks -23.9% G stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Focus Partners Advisor Solutions LLC Buys New Position in Biogen Inc. $BIIB

Focus Partners Advisor Solutions LLC has acquired a new position in Biogen Inc. by purchasing 7,689 shares valued at approximately $1,661,000 during the second quarter. Several other institutional investors also adjusted their holdings in Biogen, which continues to hold a "Moderate Buy" consensus rating …

BIIB main company
Sharemaestro market context Trend signal active 52 weeks +50.6% · Next-week setup positive 55.3% BIIB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

4,274 Shares in Casey's General Stores, Inc. $CASY Purchased by GSA Capital Partners LLP

GSA Capital Partners LLP recently acquired 4,274 shares of Casey's General Stores, Inc. (NASDAQ:CASY) for approximately $3.397 million during the second quarter. This move comes as other institutional investors have also adjusted their holdings in the company, and despite recent insider sales by CFO …

CASY main company
Sharemaestro market context Trend signal active 52 weeks +68.7% · Next-week setup positive 56.9% CASY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Focus Partners Advisor Solutions LLC Takes $4.38 Million Position in Casey's General Stores, Inc. $CASY

Focus Partners Advisor Solutions LLC has acquired a new stake of 5,511 shares, valued at approximately $4.38 million, in Casey's General Stores, Inc. during the second quarter. Several other institutional investors also adjusted their positions in the company, which reported strong quarterly earnings, surpassing …

CASY main company
Sharemaestro market context Trend signal active 52 weeks +68.7% · Next-week setup positive 56.9% CASY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Focus Partners Advisor Solutions LLC Makes New Investment in General Mills, Inc. $GIS

Focus Partners Advisor Solutions LLC has made a new investment in General Mills, Inc. (NYSE:GIS), purchasing 71,557 shares valued at approximately $2.49 million during the second quarter. This move is part of broader institutional interest, with several other major firms like State Street Corp …

GIS main company
Sharemaestro market context Price above Trend Line 52 weeks -18.5% · Next-week setup negative 43.9% GIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Focus Partners Advisor Solutions LLC Makes New $6.70 Million Investment in General Dynamics Corporation $GD

Focus Partners Advisor Solutions LLC has invested $6.70 million in General Dynamics Corporation by acquiring 18,907 shares. This comes amidst other institutional investors modifying their holdings and various analysts issuing reports with target price adjustments and ratings for General Dynamics, which recently reported strong …

GD main company
Sharemaestro market context Trend signal active 52 weeks +25.5% · Next-week setup positive 61.2% GD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Commonwealth Retirement Investments LLC Decreases Stock Holdings in Amgen Inc. $AMGN

Commonwealth Retirement Investments LLC significantly reduced its stake in Amgen Inc. by 38.4% in the second quarter, selling 4,524 shares and retaining 7,243 shares valued at approximately $2.62 million. Despite this, institutional investors collectively own 76.5% of Amgen stock, and analysts have raised price …

AMGN main company
Sharemaestro market context Trend signal active 52 weeks +44.4% AMGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Emergent Biosolutions Inc. (NYSE:EBS) Given Average Rating of "Hold" by Analysts

Emergent Biosolutions Inc. (NYSE:EBS) has received an average "Hold" rating from analysts, with an average 12-month price target of $10.00. The company recently reported better-than-expected quarterly EPS of $0.60 and revenue of $234.3 million, though it posted a negative net margin and analysts anticipate …

EBS main company
Sharemaestro market context Price below Trend Line 52 weeks -50.3% · Next-week setup negative 43.4% EBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ABN AMRO Bank N.V. Acquires New Shares in Gen Digital Inc. $GEN

ABN AMRO Bank N.V. recently acquired 576,616 shares of Gen Digital Inc. (NASDAQ:GEN), valued at approximately $14.36 million, establishing a new position in the company. Other institutional investors also adjusted their stakes, while insider activity included a sale by Travis Michael Witteveen and a …

GEN main company
Sharemaestro market context Trend signal active 52 weeks -8.4% GEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

47,412 Shares in General Motors Company $GM Acquired by Bellars Harris Wealth Management LLC

Bellars Harris Wealth Management LLC recently acquired 47,412 shares of General Motors Company (NYSE:GM) valued at approximately $3.655 million, according to its latest SEC filing. Other institutional investors have also adjusted their holdings in GM, with 92.67% of the company's stock owned by institutional …

GM main company
Sharemaestro market context Trend signal active 52 weeks +50.0% · Next-week setup positive 55.6% GM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ultragenyx Pharmaceutical Inc. Revenue Breakdown – NASDAQ:RARE

This article provides a breakdown of Ultragenyx Pharmaceutical Inc.'s (NASDAQ: RARE) revenue. Last year, the company generated $673.00 million USD, with its Novel Products segment being the top contributor at $673.00 million USD. Geographically, North America was the largest contributor, accounting for $377.00 million …

RARE main company
Sharemaestro market context Trend signal active 52 weeks -11.0% RARE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dollar General (DG), What Is Drawing Fresh Attention Now?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Dollar General (DG) is back on investors' radar after a recent share price move, with the stock closing at US$123.28. That change, alongside mixed short term returns, …

DGCO34 main company DG main company
Sharemaestro market context Price above Trend Line 52 weeks +8.8% DGCO34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

QIAGEN NV Revenue Breakdown – TRADEGATE:QIA

QIAGEN NV (TRADEGATE:QIA) reported a total revenue of €1.78 billion last year. The Diagnostic Solutions segment was the top performer, generating €683.76 million, although this was a decrease from the previous year's €723.42 million. The United States was the largest geographical contributor, accounting for …

QGEN main company
Sharemaestro market context Price above Trend Line 52 weeks -14.1% QGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PepGen’s DM1 Bet Runs Into An FDA Hold And Dilution Fears

PepGen (PEPG) is a clinical-stage biotech focused on its lead program PGN-EDODM1 for myotonic dystrophy type 1 (DM1). The company's stock performance is highly volatile and tied to clinical progress, regulatory outcomes, and financing events, including a recent FDA partial clinical hold and an …

PEPG main company
Sharemaestro market context Price below Trend Line 52 weeks +126.5% PEPG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context